Group items tagged

Getting a good night's sleep is crucial for maintaining both physical and mental health, alongside a balanced diet and regular exercise. Chronic sleep deprivation has been linked to an increased risk of serious conditions like diabetes and heart disease. So, if you're sleep deprived during weekdays, try to make up for it by getting extra sleep on weekends. A new study has revealed catching up with compensatory sleep on weekends can significantly reduce the risk of heart disease. The study conducted by the National Centre for Cardiovascular Disease in Beijing, China, found that individuals who catch up on sleep over the weekend may lower their risk of heart disease by one-fifth. Study co-author Yanjun Song from the State Key Laboratory of Infectious Disease at Fuwai Hospital emphasised that the benefit of compensatory sleep was even more pronounced among individuals who regularly experience inadequate sleep on weekdays. The researchers used data from 90,903 subjects involved in the UK Biobank project to evaluate the relationship between compensated weekend sleep and heart disease. More than 21 per cent of the participants were identified as sleep-deprived - defined as getting less than seven hours of sleep per night.

Heart valve replacement surgery is a life-saving procedure that offers numerous benefits to individuals suffering from valve diseases such as stenosis or regurgitation. Here are some of the key advantages: 1. Improved Blood Flow and Heart Function 2. Increased Energy Levels 3. Reduced Risk of Heart Failure 4. Relief from Symptoms 5. Long-Term Health Benefits 6. Reduced Need for Medications

The National Institute for Health and Care Excellence (NICE) has recommended icosapent ethyl also called Vazkepa manufactured by Amarin for adults who have cardiovascular disease with controlled LDL-C levels taking a statin. It's final draft guidance is expected to be available on the July 20. Nearly half a million people are expected to benefit from the first licensed treatment shown to reduce the risk of heart attacks and strokes in people with controlled low-density lipoprotein cholesterol (LDL-C - sometimes called "bad" cholesterol) who are taking a statin and who have raised levels of triglycerides. NICE said: "Clinical trial evidence suggests that for people with raised triglycerides who have LDL-C levels controlled by statins, and who have cardiovascular disease, icosapent ethyl reduces their risk of cardiovascular events by over a quarter compared with placebo. Helen Knight, interim director of medicines evaluation at NICE, said: "Icosapent ethyl is the first licensed treatment of its kind for people who are at risk of heart attacks and strokes despite well controlled LDL cholesterol because they have raised blood fats. And although lifestyle changes, including diet and exercise, can help to reduce their risk, these may not work for everyone.

ScienceDaily (Mar. 11, 2009) - For every gram of salt that Americans reduce in their diets daily, a quarter of a million fewer new heart disease cases and over 200,000 fewer deaths would occur over a decade, researchers said at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication of semaglutide (Wegovy), authorising its use to reduce the risk of serious heart problems and strokes in adults who are obese or overweight. Semaglutide, a GLP-1 receptor agonist, was previously approved for use in the treatment of obesity and weight management, to be used alongside diet, physical activity and behavioural support. The latest approval establishes it as the first weight loss drug to be prescribed to prevent cardiovascular events, such as cardiovascular death, non-fatal heart attack and non-fatal stroke, in people with established cardiovascular disease and a Body Mass Index (BMI) higher or equal to 27 kg/m2. Novo Nordisk, the manufacturer of Wegovy, received this authorisation on 23 July following compelling evidence from a recent post-approval clinical study involving over 17,600 participants. The study demonstrated that Wegovy, administered at a dose of 2.4 mg once weekly via subcutaneous injection for up to five years, significantly lowers the incidence of major adverse cardiovascular events (MACE) by 20 per cent compared to a placebo.

In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative cardiometabolic clinic. The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust. This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack. Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together. "We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."

The journey for patients to quit smoking can be challenging, but with the right strategies and support, it is achievable. Smoking cessation is a critical step for patients towards improving overall health and well-being. We caught up with Thorrun Govind, pharmacist, TV health expert and pharmacy lawyer at Brabners for her top tips. Govind notes that smoking is a leading cause of preventable diseases and deaths worldwide. It is associated with numerous health issues, including lung cancer, heart disease, stroke, and chronic obstructive pulmonary disease (COPD). Quitting smoking can significantly reduce the risk of these conditions and improve quality of life. Within weeks of quitting, individuals often experience improved lung function, better circulation, and enhanced sense of taste and smell. Govind advises that; After 20 minutes of quitting your pulse rate, will already be starting to return to normal. After 48 hours of quitting your carbon monoxide levels have dropped to that of a non-smoker. Your lungs are clearing out mucus and your senses of taste and smell are improving. After 1 year your risk of heart attack will have halved compared with a smoker's. This piece explores the various methods and benefits of smoking cessation.

Heart valve disease can develop due to aging, infections, or underlying health conditions. While some causes are unavoidable, you can take preventive measures to maintain heart valve health and reduce the risk of complications.

If wheat is so bad, what about all the other grains? First of all, I demonize wheat because of its top-of-the-list role in triggering: --Appetite--Wheat increases hunger dramatically --Insulin --Blood sugar--Wheat is worse than table sugar in triggering a rapid, large rise in blood sugar --Triglycerides --Small LDL particles--the number one cause for heart disease in the U.S. --Reduced HDL --Diabetes --Autoimmune diseases--Most notably celiac disease and thyroiditis. Most other "healthy, whole grains" aren't quite as bad. It's a matter of degree.

Esperion Therapeutics' non-statin therapy "bempedoic acid" has shown modest results in reducing the risk of major cardiovascular events in statin-intolerant patients in the cholesterol lowering via bempedoic acid, an ACL-inhibiting regimen (CLEAR Outcomes) trial, revealed GlobalData, a leading data and analytics company. As a result, there is substantial room for improvement in this space as a potential approval is expected in Australia in near-term based on these results, said GlobalData. According to GlobalData's Pharmaceutical Intelligence Center, the total number of diagnosed prevalent cases of dyslipidemia in Australia is expected to increase at a compound annual growth rate of approximately 1.2% from 5.2 million in 2022 to 5.4 million in 2025. Neha Myneni, Pharma Analyst at GlobalData, comments: "Bempedoic acid joins several statin alternatives that have shown the potential to reduce cardiac illnesses. However, with not much significant improvement in the outcomes, there exists a clear room for improvement for non-statin therapies in this space." Bempedoic acid is the sixth class of cholesterol-lowering drugs (other than cholesteryl-ester transfer protein isoform (CETPi) inhibitors), that has demonstrated the potential to reduce heart attacks and strokes. Other class of therapies with similar potential currently marketed in Australia include statins, bile acid resins, niacin, ezetimibe, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (alirocumab, evolocumab, and inclisiran).

An ever-increasing emphasis is being placed on getting and staying fit and mobile, whatever your age, with good reason. Regular aerobic exercise (physical activity which gets the heart beating faster) helps patients to: Reduce or maintain body weight Reduce the risk of heart disease, strokes and diabetes Control blood sugar (helpful for diabetics) Maintain mobility and muscle strength, allowing daily activities to be undertaken more easily Improve mood, physical activity can be beneficial for everyone. However, injuries sometimes happen during exercise or everyday life. Collectively, injuries to tendons, ligaments and/or skeletal muscle, are referred to as musculoskeletal soft tissue injuries. Post pandemic pharmacists are now the first port of call for many seeking to self-treat so it is important that information, advice and a wide range of treatment options are available. While the precise incidence and prevalence of such disorders are difficult to define, they are known to be the most common rheumatic causes of sickness absences from work. Indeed, soft tissue complaints account for up to 59 per cent of new patient referrals to rheumatology practice and up to 15 per cent of consultations in primary care. Ankle injuries are very common with an estimated incidence of one per 100,000 population per day. They account for about one in five of all sports related injuries. The majority of ankle injuries are moderate ligament sprains. With appropriate treatment the majority of patients should be able to return to normal activities within a few weeks.

Soybean has great health benefits,reduce the risk diabetics,make the bone stronger,prevention of cancers,help to prevent heart disease by reducing cholesterol, improve potential mental health.

Boots UK's chief pharmacist has been encouraging people to get a flu vaccination by the end of November to help protect themselves, their loved ones and the NHS this festive season. Flu cases in the UK are usually highest in the winter months, from December to March. This year, the UK has seen a rise in cases earlier than usual, and therefore Claire Nevinson, superintendent pharmacist at Boots, reminds people that it is even more important to get protected early to help reduce the risk of spreading the virus due to increased mixing at Christmas parties and family get togethers. Approximately 33 million people are eligible for the free NHS flu jab, including those over 50 years of age, pregnant women and those with medical conditions such as diabetes or heart disease. The pharmacy multiple says it offers the winter flu jab service, which is suitable for those eligible for the free NHS flu jab as well as privately, adding that it has already administered over one million flu vaccinations this season. Ms Nevinson explains: "December is a time to get together with friends and family to celebrate the month's festivities. It's a good idea to plan ahead to ensure you have your flu jab, and your COVID-19 booster vaccination if you are eligible, if you've not had them already, this the best way to protect yourself and reduce the risk of passing the viruses to others.

HRT or Hormone Replacement Therapy is a standard treatment for night sweats, hot flashes, irritability, vaginal dryness, and also results in changing the sleeping patterns. Apart from treating these uncomfortable conditions, HRT is also useful in reducing the chances of heart disease. But just like many other drugs, HRT therapies also have risks. Constant use of Hormone Replacement Therapy might cause breast cancer in women.

Thigh Support Applications Mild support to quadriceps and hamstrings. Relieves inflammation and stiffness. Firm compression and therapeutic warmth. Psychological support to geriatric patients. Sports injury, sprains and strains. Post-surgical rehabilitation. Burn care. Thigh Support Features Strong Compression. Four way stretch. Dermophillic. Durable. Breathable and comfortable. Thigh Support Measurements Measure circumference around mid thigh - approximately 6 inches above knee. Size Chart - Size Inches CM Small 14.8 to 17.2 37 to 43 Medium 17.2 to 19.6 43 to 49 Large 19.6 to 22.0 49 to 55

Tynor Pattelar Support Patellar support is designed to lift the patella and alleviate symptoms of pain, inflammation and discomfort associated with knee degeneration, without restricting circulation. Anatomically shaped Pad Enhanced Propioception Skin-friendly materials Customized compression. Tynor Pattelar Support Features Anatomical pad design Lifts and positions the patella properly Optimal compression of the patellar tendon Ensures strong grip of the product Silicon material of pad. Absorbs all the vibrations around the patella and the patellar tendon. Provides comfortable compression to the patellar tendon. Support the patella. Nodular surface Propioception Provides good massage Enhances blood circulation to the area Enhances healing Reverse buckle design One size fits all Provides customized compression Easy to wear. Tynor Pattelar Support Measurements Size Chart - Size Inches CM Universal 12 to 20 30 to 50